Sun.Dec 03, 2023

article thumbnail

Lilly's Jaypirca blazes leukemia trail with FDA nod, fast confirmatory trial filing

Fierce Pharma

As AbbVie, Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class. | As AbbVie and Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class with an accelerated approval in post BTK/BCL-2 chronic lymphocytic leukemia.

FDA 295
article thumbnail

Rising Cost of New Medications, Will the People Who Need Them Most be able to Afford them?

MedCity News

Healthcare has traditionally been built around the convenience of the provider and not the patient. Worse, it tends to treat all patients the same regardless of the condition they are trying to manage. If we want to improve medication compliance, we have to make access, support, and most importantly financial assistance a priority.

Medical 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wischenbart Report On Global 50 Publishers Arrives

Copyright Clearance Center

Books remain a dominant format, though reading and discussing stories, as well as the IP generated from books, have become integrated in consumers’ experiences and on publishers’ spreadsheets.

97
article thumbnail

Navigating What Comes Next for mRNA Therapeutics

MedCity News

The next era for mRNA-based therapeutics and vaccines is here, and it’s time to move from an R&D mindset to a focus on long-term success with mRNA and bringing these innovative therapeutics to patients at scale.

Patients 110
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Efficient Event Planning: Unlocking Benefits on a Single Platform

Veeva

Throughout the history of life sciences companies, events have played a crucial role as a promotional avenue for introducing new products and offering scientific education. Customers find value in attending life sciences events for several reasons. Firstly, these events serve as a platform for increasing awareness and engagement, allowing attendees to stay informed about the latest developments and advancements in the field.

article thumbnail

3 Trends Employers Should Watch Out for in 2024

MedCity News

The top three areas of concern for employers in 2024 include rising healthcare costs, mental health challenges and cancer care, according to a recent report from Business Group on Health.

More Trending

article thumbnail

Unmasking the STI Crisis: At-Home Testing’s Role in Overcoming STI Testing

MedCity News

With at-home STI testing kits, people can get tested in the comfort and privacy of their own homes. These test kits are available at most pharmacies and are easy to use.

108
108
article thumbnail

Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool

Copyright Clearance Center

The post Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool appeared first on Copyright Clearance Center.

40
article thumbnail

Bright Uro Snags $23M To Make Urology Diagnostics Easier for Providers & Patients

MedCity News

Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company’s CEO said.